High-Concentration Protein Formulations: How High is High?

European Journal of Pharmaceutics and Biopharmaceutics(2017)

引用 116|浏览52
暂无评分
摘要
High-concentration protein formulation (HCPF) is a term that is used to describe protein formulations, mostly monoclonal antibody (mAb) drugs, at high protein concentration. The concentration is rarely defined, with typical ranges varying between 50 and 150mg/ml for mAbs. The term HCPF is meant to include and express specific solution properties of formulations that are prone to appear at high protein concentrations such as high viscosity, high opalescence, phase separation, gel formation or the increased propensity for protein particle formation. Thus the term HCPF can be understood as a descriptor of protein formulations, usually at high protein (monoclonal antibody) concentrations, which have specific solution, stability and colloidal properties that differ from formulations at low protein concentration (e.g. at 10mg/ml).
更多
查看译文
关键词
High-concentration,Protein,HCLF,HCPF,Monoclonal antibody,Formulation,Packing characteristics,Solubility,Colloidal properties
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要